A New Care Model for Patients With Complicated Multimorbidity

NCT ID: NCT05406193

Last Updated: 2023-05-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

350 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-11-01

Study Completion Date

2024-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients with complex multimorbidity experience a high treatment burden, fragmentation of care and poor clinical outcomes. General practice is the key organizational setting in terms of offering these patients integrated, longitudinal, and patient-centered care. Therefore, we propose a new general practice based model to improve overview, patient involvement and integration of care. The new care model consist of a teaching session on multimorbidity for the health care professionals, a prolonged overview consultation for patients with complex multimorbidity with the general practitioner, resulting in an individual care plan shared with the municipalities and secondary care, access to cross-sectoral video conferences with secondary care specialists and. Control practices provide health care as usual. We evaluate the care model in a cluster-randomized non-blinded, parallel-group trial in general practice. Fourteen general practices are allocated 1:1 to either intervention or control. We evaluate the effectiveness of the intervention with patient-reported questionnaire at baseline, 6-month follow-up, and 12-month follow-up. Primary outcome measure is the Patient Assessment of Chronic Illness Care (PACIC). Secondary outcome measure includes patient-reported quality of life and the treatment burden for the patients with multimorbidity. Furthermore, the project include a process evaluation of the complex intervention with the objective to assess how the intervention is delivered and to identify important facilitators and barriers for implementing the intervention. The new model is integrated into the existing health care system structures and has the potential for a sustainable improvement in care for patients with complex multimorbidity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multimorbidity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention (CIM2)

An extended overview consultation, lasting 45 minutes, with the general practitioner, the patient (and maybe a relative), and the care coordinator. An individual care plan is developed, covering planned activities in the three sectors (general practice, municipality, and hospital) that will take place within the 12-month intervention period. General practice coordinates the planned patient care between general practice, the municipality, and the hospital, and follow-up on the execution of planned healthcare activities. The individual care plan is shared electronically with the healthcare center in the municipality and with the outpatient clinics using the standard IT-communication tool provided by MedCom and a routinely used national standard in general practice, hospitals, and municipalities.

Group Type EXPERIMENTAL

Patient-centred complex intervention in complicated multimorbidity (CIM2)

Intervention Type OTHER

CIM2 is the second version of the Patient-centred complex intervention in complicated multimorbidity

Usual care

Patients with a general practitioner allocated to the control group will receive usual care.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Patient-centred complex intervention in complicated multimorbidity (CIM2)

CIM2 is the second version of the Patient-centred complex intervention in complicated multimorbidity

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Has more than one of the 3 common chronic diseases (diabetes, chronic obstructive pulmonary, chronic heart conditions)
2. Has been hospitalised, or visited an outpatient clinic due to their chronic diseases during the previous year
3. Take at least five different prescription drugs assessed from the Shared Medicine Card recording in the general practice
4. The general practitioner or the nurse in the practice recognise the patient as a "demanding" patient with complicated multimorbidity that will benefit from an overview consultation.

Exclusion Criteria

* Patients who cannot speak Danish,
* Patients who cannot give informed consent,
* Patients who have a life expectancy of less than 12 months
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Slagelse Hospital

OTHER

Sponsor Role lead

University of Copenhagen

OTHER

Sponsor Role collaborator

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Anne Frølich, Professor

Role: STUDY_CHAIR

Innovation and Research Centre for Multimorbidity, Slagelse hospital, Region Zealand

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Lægerne Kanaltorvet

Albertslund, , Denmark

Site Status ACTIVE_NOT_RECRUITING

Thorkil Christensen

Albertslund, , Denmark

Site Status ACTIVE_NOT_RECRUITING

Brøndbyøster Torv

Brøndby, , Denmark

Site Status ACTIVE_NOT_RECRUITING

Lægerne i Brohuset

Ishøj, , Denmark

Site Status ACTIVE_NOT_RECRUITING

Lægecenter Korsør

Korsør, , Denmark

Site Status ACTIVE_NOT_RECRUITING

Læge Depenau vej-Hansen

Slagelse, , Denmark

Site Status ACTIVE_NOT_RECRUITING

Læge Jørgen Larsen

Slagelse, , Denmark

Site Status WITHDRAWN

Læge Lene Stiggaard

Slagelse, , Denmark

Site Status RECRUITING

Lægerne Reventlow, Wolfhagen og Bendtsen

Slagelse, , Denmark

Site Status RECRUITING

Lægerne ved Lystskoven

Slagelse, , Denmark

Site Status ACTIVE_NOT_RECRUITING

Lægerne Vallensbæk Nord

Vallensbæk, , Denmark

Site Status ACTIVE_NOT_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Anne Frølich, Professor

Role: CONTACT

+45 27121622

Sanne L Lundstrøm, Senior Researcher

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lene Stiggaard, GP

Role: primary

Johan Reventlow, GP

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Lundstrom SL, Kamstrup-Larsen N, Barrett BA, Jorgensen LMB, Hansen SS, Andersen JS, Friderichsen B, Stockmarr A, Frolich A. A patient-centred care model for patients with complicated multimorbidity: Protocol for a pilot cluster randomised trial in general practice, municipalities, and hospitals. PLoS One. 2024 Dec 4;19(12):e0310697. doi: 10.1371/journal.pone.0310697. eCollection 2024.

Reference Type DERIVED
PMID: 39630823 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MM14

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.